Microbiological and pharmacotoxicological profile of nifuratel and its favourable risk/benefit ratio for the treatment of vulvo-vaginal infections

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 1, 2002, Pages 8-13

  Mendling, Werner ^a   Mailland, Federico ^a  

^a Polichem SA   (Switzerland)

Author keywords

CAS 4936 47 4; Inimur ; Macmiror ; Nifuratel, antimicrobial activity, pharmaco toxicological profile, resistance phenomena; Vulvo vaginal infections

Indexed keywords

FURAN DERIVATIVE; METRONIDAZOLE; NIFURATEL; ANTIFUNGAL AGENT;

ANTIPROTOZOAL ACTIVITY; CANDIDA; CHLAMYDIA TRACHOMATIS; DOG; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYCOPLASMA; NONHUMAN; PREGNANCY; RAT; REVIEW; TERATOGENICITY; TOXICITY TESTING; TRICHOMONAS; VULVOVAGINITIS; ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM; DRUG EFFECT; FEMALE; FUNGUS; MICROBIOLOGY; RISK ASSESSMENT; VAGINA DISEASE;

ANIMALS; ANTIFUNGAL AGENTS; BACTERIA; DRUG RESISTANCE, MICROBIAL; FEMALE; FUNGI; HUMANS; NIFURATEL; RISK ASSESSMENT; VAGINAL DISEASES;

EID: 0036149767     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299849     Document Type: Review

References (39)

1. Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis
2. Genital yeast infections
3. Sexually transmitted diseases and reproductive tract infections among contraceptive users
4. Candidal vulvovaginitis
5. The epidemiology of vulvovaginal candidiasis: Risk factor
6. Bacterial vaginosis, ethnicity, and use of genital cleaning agents: A case control study
7. Vulvovaginitis in healthy women
8. Diagnosis and management of infectious vaginitis
9. Indagine epidemiologica sulle vulvo vaginiti in Italia
10. Comparison of oral and vaginal metronidazole therapy for non-specific bacterial vaginosis
11. Non specific vaginitis. Role of haemophilus vaginalis and treatment with metronidazole
12. Clindamycin versus metronidazole in the treatment of bacterial vaginosis
13. Treatment of sexually transmitted vaginosis/vaginitis
14. Bacterial vaginosis
15. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates
16. Toxicological evaluation of metronidazole with particular reference to carcinogenic, mutagenic and teratogenic potential
17. Evaluation and management of vaginitis
18. Attività antimicrobica del nifuratel
19. The efficacy of Macmiror in the treatment of female genitourinary trichomoniasis
20. Frequency, pathogenesis and prevention of fungal complications of trichomonacide therapy
21. Vaginitis. Un nuevo tratamiento
22. Treatment of vaginal Trichomonadosis with nifuratel
23. Il Macmiror nella terapia della trichomoniasi vaginale
24. Klinische auswertung aktiver arzneimittel gegen trichomoniasis vaginalis im dopple-blindversuch
25. Therapeutic efficacy of the Italian compound macmiror (nifuratel) in female patients with trichomoniasis
26. Effekten av nifuratel och metronidazol vid behandling av trichomoniasis
27. Nuovi orientamenti nella terapia della trichomoniasi femminile
28. Sull'attività tricomonicida e battericida di thiodinone
29. Proprietà biologiche dell'N-(5-nitro-2-furfurilidene)- 3-amino-5-metilmercaptometil-2-ossazolidone
30. Investigaciones comparativas sobre algunos compuestos de activitad tricomonicida
31. Ovules mystatine/nifuratel LF.70. Etude de l'activité in vitro
32. Comparative in vitro activity of five nitrofurans
33. Etude toxicologique de la méthylmercadone N-(nitro-5′-furfurylidène-2′)amino-3-mé thylmercaptométhyò-5 oxazolidone-2
34. Nifuratel in urinary infections